Nowoczesne metody diagnostyki kardiotoksycznosci antracyklin u pacjentow z chloniakami

Abstract

Author(s): Beata Kumiega, Andrzej Pluta, Jacek Krzanowski

Anthracyclines, show a strong antitumour activity in the treatment of solid and haematological malignancies. They may be responsible for cardiac side effects. Initially, cardiac damage induced by anthracyclines is subclinical, however increasingly impaired cardiac function can result chronic heart failure. The assessment of the myocardial damage, especially at its initial stage is very important however difficult. There is a continuous need for new methods introduction of early detection of cardiac damage.

<

Share this article

Awards Nomination

Editors List

  • Ahmed Hussien Alshewered

    University of Basrah College of Medicine, Iraq

  • Sudhakar Tummala

    Department of Electronics and Communication Engineering SRM University – AP, Andhra Pradesh

     

     

     

  • Alphonse Laya

    Supervisor of Biochemistry Lab and PhD. students of Faculty of Science, Department of Chemistry and Department of Chemis

     

  • Fava Maria Giovanna

     

  • Manuprasad Avaronnan

Google Scholar citation report
Citations : 558

Onkologia i Radioterapia received 558 citations as per Google Scholar report

Onkologia i Radioterapia peer review process verified at publons
Indexed In
  • Directory of Open Access Journals
  • Scimago
  • SCOPUS
  • EBSCO A-Z
  • MIAR
  • Euro Pub
  • Google Scholar
  • Medical Project Poland
  • PUBMED
  • Cancer Index
  • Gdansk University of Technology, Ministry Points 20